US 12,138,184 B2
Transcatheter heart valve having paravalvular leakage seal
Ali Shahriari, Hillsboro Beach, FL (US)
Assigned to Aortic Innovations, LLC, Hillsboro Beach, FL (US)
Filed by Aortic Innovations, LLC, Hillsboro Beach, FL (US)
Filed on Jan. 30, 2024, as Appl. No. 18/426,389.
Application 14/569,306 is a division of application No. 13/706,896, filed on Dec. 6, 2012, granted, now 8,940,040, issued on Jan. 27, 2015.
Application 18/426,389 is a continuation of application No. 18/377,264, filed on Oct. 5, 2023, granted, now 11,890,188.
Application 18/377,264 is a continuation of application No. 18/210,674, filed on Jun. 16, 2023, granted, now 11,883,284, issued on Jan. 30, 2024.
Application 18/210,674 is a continuation of application No. 16/935,261, filed on Jul. 22, 2020, granted, now 11,806,259, issued on Nov. 7, 2023.
Application 16/935,261 is a continuation of application No. 16/808,137, filed on Mar. 3, 2020, granted, now 10,792,172, issued on Oct. 6, 2020.
Application 16/808,137 is a continuation of application No. 16/736,879, filed on Jan. 8, 2020, granted, now 10,842,655, issued on Nov. 24, 2020.
Application 16/736,879 is a continuation of application No. 16/042,286, filed on Jul. 23, 2018, granted, now 10,555,823, issued on Feb. 11, 2020.
Application 16/042,286 is a continuation of application No. 14/614,628, filed on Feb. 5, 2015, granted, now 10,028,848, issued on Jul. 24, 2018.
Application 14/614,628 is a continuation of application No. 14/569,306, filed on Dec. 12, 2014, granted, now 9,339,399, issued on May 17, 2016.
Claims priority of provisional application 61/723,446, filed on Nov. 7, 2012.
Claims priority of provisional application 61/567,458, filed on Dec. 6, 2011.
Prior Publication US 2024/0164917 A1, May 23, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61F 2/24 (2006.01); A61F 2/07 (2013.01); A61F 2/82 (2013.01); A61F 2/856 (2013.01); A61F 2/962 (2013.01); A61F 2/06 (2013.01); A61F 2/86 (2013.01); A61F 2/89 (2013.01); A61F 2/90 (2013.01)
CPC A61F 2/82 (2013.01) [A61F 2/07 (2013.01); A61F 2/2418 (2013.01); A61F 2/856 (2013.01); A61F 2/962 (2013.01); A61F 2002/061 (2013.01); A61F 2002/067 (2013.01); A61F 2/24 (2013.01); A61F 2/86 (2013.01); A61F 2/89 (2013.01); A61F 2/90 (2013.01); A61F 2210/00 (2013.01); A61F 2210/0014 (2013.01); A61F 2210/0057 (2013.01); A61F 2220/0008 (2013.01); A61F 2220/0016 (2013.01); A61F 2220/0025 (2013.01); A61F 2220/0058 (2013.01); A61F 2220/0075 (2013.01); A61F 2230/001 (2013.01); A61F 2230/0034 (2013.01); A61F 2230/0067 (2013.01); A61F 2250/0039 (2013.01); A61F 2250/0048 (2013.01); A61F 2250/0069 (2013.01)] 11 Claims
OG exemplary drawing
 
1. An endovascular prosthetic heart valve assembly for use in a patient, the heart valve assembly comprising:
a stent frame configured for being radially expandable from a radially compressed orientation to a radially expanded orientation;
a leaflet assembly;
a polymer covering engaging the frame; and
a plurality of flexible fibers that extend outwardly away from the frame,
wherein the prosthetic heart valve assembly is configured to be endovascularly deployed through a femoral artery of the patient,
wherein the plurality of fibers is configured for being pressed against native leaflets of the patient when the prosthetic heart valve assembly is endovascularly deployed to the radially expanded orientation within a native heart valve annulus of the patient,
wherein the prosthetic heart valve assembly defines a spacing extending through a thickness of the plurality of fibers that is created by a distance between adjacent fibers thereof through to the polymer covering,
wherein, compression of the plurality of fibers in response to expansion of the prosthetic heart valve assembly is configured to compress the plurality of fibers relative to the spacings to create a seal thereabout by reducing a porosity of the spacing.